HomeITCI • NASDAQ
add
Intra-Cellular Therapies Inc
Previous close
$85.45
Day range
$84.74 - $86.10
Year range
$58.14 - $93.45
Market cap
9.08B USD
Avg Volume
667.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 175.38M | 39.00% |
Operating expense | 132.10M | 25.56% |
Net income | -26.32M | -8.52% |
Net profit margin | -15.01 | 21.94% |
Earnings per share | -0.25 | 0.00% |
EBITDA | -38.71M | -30.88% |
Effective tax rate | -1.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.01B | 104.16% |
Total assets | 1.32B | 84.55% |
Total liabilities | 179.62M | 53.54% |
Total equity | 1.14B | — |
Shares outstanding | 106.02M | — |
Price to book | 7.91 | — |
Return on assets | -7.34% | — |
Return on capital | -8.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.32M | -8.52% |
Cash from operations | -26.52M | -4.97% |
Cash from investing | -209.20M | -937.35% |
Cash from financing | 6.73M | 160.91% |
Net change in cash | -228.99M | -434.33% |
Free cash flow | -26.87M | -52.74% |
About
Founded
2002
Headquarters
Website
Employees
610
